Back
Top 0.6%
18.4%
Top 0.5%
11.4%
Top 60%
9.3%
Top 0.5%
6.7%
#1
6.7%
Top 48%
5.8%
Top 0.6%
5.2%
Top 7%
5.2%
Top 3%
4.3%
Top 0.5%
4.3%
Top 32%
2.9%
Top 8%
2.0%
Top 47%
2.0%
Top 1%
1.0%
Top 4%
1.0%
Top 8%
0.7%
Neoadjuvant Immunotherapy and Chemoradiation Followed by Esophagectomy for Esophageal Cancer
2023-10-02
oncology
Title + abstract only
View on medRxiv
Show abstract
BackgroundTreatment of locally advanced esophageal cancer includes neoadjuvant chemoradiation (chemoRT) and esophagectomy. We evaluated perioperative and oncologic outcomes among patients who received neoadjuvant chemoRT and immunotherapy (I/O). MethodsAdults who underwent esophagectomy following neoadjuvant chemoRT or chemoRT+I/O for T1-4, N0-3, M0 esophageal cancer were identified from the National Cancer Database (2012-2020). Unadjusted, propensity score-matched, and Cox proportional hazards...
Predicted journal destinations
1
Cancers
57 training papers
2
Frontiers in Oncology
34 training papers
3
PLOS ONE
1737 training papers
4
Clinical Cancer Research
22 training papers
5
BMC Cancer
21 training papers
6
Scientific Reports
701 training papers
7
British Journal of Cancer
22 training papers
8
eLife
262 training papers
9
Frontiers in Immunology
140 training papers
10
Cancer Medicine
17 training papers
11
Nature Communications
483 training papers
12
JAMA Network Open
125 training papers
13
BMJ Open
553 training papers
14
International Journal of Cancer
18 training papers
15
Diagnostics
36 training papers
16
PeerJ
46 training papers